Investigating the Bactericidal Effect of Probiotics on Chromogenic Bacteria in Children An In Vivo and In Vitro Study
NCT ID: NCT06834815
Last Updated: 2025-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
9 participants
INTERVENTIONAL
2024-11-05
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics in Children With Early Childhood Caries
NCT03998306
Effects of Probiotics on Streptococcus Mutans ve Lactobacillus Spp
NCT05859646
Consumption of Probiotics on Salivary Bacteria Causing Dental Caries
NCT02752594
Effect of Probiotic Drink on Number of Salivary Mutans Streptococci in School Going Children
NCT01943123
Acid Production in Dental Plaque After Exposure to Probiotic Bacteria
NCT01700712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
An unstimulated salivary sample will be taken from patients having black stains. The two types of bacteria of each condition will be cultured, amplified, and measured in the laboratory from the saliva of these patients. After that, one type of probiotics will be applied to these bacteria separately and the same bacterial measurement will be done to evaluate the bactericidal effect of the probiotics on these bacteria, aiming to find the minimal inhibitory concentration of the probiotics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
before and after probiotic administration
all patients will submit an unstimulated salivary sample of 1ml will in sealed test tube
* then the patients will receive probiotics for 14 days .
* after 14 days and another salivary sample will be collected
Probiotic with Prebiotic
After assigning the patients , all patients will submit an unstimulated salivary sample of 1ml will in sealed test tubes then stored in a deep freezer until microbiological evaluation, then they'll receive an oral prophylaxis session.
* The patients will receive probiotics for 14 days given to them in a sealed box.
* All patients will be followed up after 14 days and another salivary sample will be collected and sent for microbiological assessment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic with Prebiotic
After assigning the patients , all patients will submit an unstimulated salivary sample of 1ml will in sealed test tubes then stored in a deep freezer until microbiological evaluation, then they'll receive an oral prophylaxis session.
* The patients will receive probiotics for 14 days given to them in a sealed box.
* All patients will be followed up after 14 days and another salivary sample will be collected and sent for microbiological assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medically free patients
Exclusion Criteria
* Patients on antibiotic treatment or any other medication for the last 2 weeks.
* Patients allergic to prophylaxis powder.
* Parents refusing to participate
6 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of dentistry .Ain shams university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDASU-Rec IR102420
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.